Donate

Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

PATH is advancing health equity around the world

April 2, 2025
Uganda launches Africa’s largest malaria vaccine rollout to date
March 25, 2025
Fewer shots, more protection: The promise of combination vaccines
March 20, 2025
How local heroes are reshaping disability care in Mozambique

Stay informed

Featured Press Coverage

April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
May 5, 2025
Ensuring oxygen access is essential to achieving health for all
Devex
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. The looming antibiotic emergency and why the time for global action is now
    PATH’s Nikolaj Gilbert and Dame Sally Davies write in The Telegraph about drug-resistant infections that are outpacing our ability to treat them—and how the global community must come together to address this growing global threat.
    Published: March 2025
  2. PATH part of $12.7M GHIT Fund initiative for malaria, NTDs research.
    PATH is among the global partners receiving funding from the GHIT Fund’s $12.7 million investment to advance new diagnostics and drug development for malaria and neglected tropical diseases (NTDs).
    Published: January 2025
  3. Opinion: GenAI for global health — the bear and the bull case
    Dr. Bilal Mateen, PATH’s Chief AI Officer, highlights GenAI’s potential in diagnostics, disease surveillance, and health communication while addressing challenges like data privacy and equity.
    Published: December 2024
  4. Life-saving advances in vaccines pave the way for healthier futures
    Dr. Cathy Ndiaye, Director of HPV Vaccine Programs at PATH, shares her personal connection to the fight against cervical cancer and her efforts to address disparities in prevention and care.
    Published: November 2024
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

952 Item s
952 Item s
    Date
    From
    To
  1. PATH and Walter Reed Army Institute of Research announce largest-ever controlled malaria infection study
    Study in adult US volunteers to investigate which changes in the RTS,S malaria vaccine candidate regimen increase protection the most
    Published: September 2017
    Press Release
  2. PATH boosts leadership in developing and introducing urgently needed vaccines
    PATH’s Center for Vaccine Innovation and Access attracts top global talent and additional $120 million investment from the Bill & Melinda Gates Foundation
    Published: September 2017
    Press Release
  3. PATH nominated for Saving Lives at Birth grants to accelerate diagnostic and device innovations that prevent maternal and infant deaths at birth
    The three ideas from PATH were among 15 selected out of a pool of more than 550 submissions from public, private, and academic institutions worldwide as the most promising solutions to save lives in developing countries within the critical 48 hours around the time of birth.
    Published: August 2017
    Announcement
  4. PATH celebrates the extension of its digital health partnership with the Government of Tanzania
    Second phase of the Data Use Partnership will strengthen Tanzania’s ability to use data to transform its health sector
    Published: August 2017
    Announcement
  5. PATH partners with the Mahidol Oxford Tropical Medicine Research Unit on first study of the RTS,S malaria vaccine in Asia
    Study is the first step toward understanding the vaccine’s potential role in elimination campaigns and combating drug resistance across Southeast Asia’s Greater Mekong Subregion
    Published: August 2017
    Announcement
Previous
Next